ArticleCancer biology & therapy2016

Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations.

Do-Hee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.